Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Genetic Testing for Inherited Eye Disease

Genetic Testing for Inherited Eye Disease SPECIAL ARTICLE Edwin M. Stone, MD, PhD he data, devices, and molecular techniques that have become part of the practice of medicine as a result of the Human Genome Project are for most clinicians both inspir- ing and intimidating. While the potential for tests that can help make very accurate T diagnoses of rare genetic diseases and that can identify genetic predispositions to more common ones is exciting, the translation of this concept to practice has been slower and more com- plicated than most people would have imagined. The reasons for the slow translation of ge- Genetic eye diseases range in preva- nomic discoveries from the laboratory to lence from common disorders like macu- the clinic range from the vagaries of in- lar degeneration, which affects as many as tellectual property law to the different strat- 1 in 3 people older than 75 years, to spe- egies that various countries have chosen cific subtypes of rare conditions that each to pay for the medical care of their citi- occur in only a few people in the United zens. However, our understanding of the States per year. In the future, genetic test- genes involved in inherited eye disease is ing http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

Genetic Testing for Inherited Eye Disease

JAMA Ophthalmology , Volume 125 (2) – Feb 1, 2007

Loading next page...
 
/lp/american-medical-association/genetic-testing-for-inherited-eye-disease-M7fb9Fga2V

References (38)

Publisher
American Medical Association
Copyright
Copyright 2007 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/archopht.125.2.205
pmid
17296896
Publisher site
See Article on Publisher Site

Abstract

SPECIAL ARTICLE Edwin M. Stone, MD, PhD he data, devices, and molecular techniques that have become part of the practice of medicine as a result of the Human Genome Project are for most clinicians both inspir- ing and intimidating. While the potential for tests that can help make very accurate T diagnoses of rare genetic diseases and that can identify genetic predispositions to more common ones is exciting, the translation of this concept to practice has been slower and more com- plicated than most people would have imagined. The reasons for the slow translation of ge- Genetic eye diseases range in preva- nomic discoveries from the laboratory to lence from common disorders like macu- the clinic range from the vagaries of in- lar degeneration, which affects as many as tellectual property law to the different strat- 1 in 3 people older than 75 years, to spe- egies that various countries have chosen cific subtypes of rare conditions that each to pay for the medical care of their citi- occur in only a few people in the United zens. However, our understanding of the States per year. In the future, genetic test- genes involved in inherited eye disease is ing

Journal

JAMA OphthalmologyAmerican Medical Association

Published: Feb 1, 2007

There are no references for this article.